The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Tongue Neoplasms

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Tongue Neoplasms


Psychiatry related information on Tongue Neoplasms


High impact information on Tongue Neoplasms


Chemical compound and disease context of Tongue Neoplasms


Biological context of Tongue Neoplasms


Anatomical context of Tongue Neoplasms


Gene context of Tongue Neoplasms


Analytical, diagnostic and therapeutic context of Tongue Neoplasms


  1. MM-1, a c-Myc-binding protein, is a candidate for a tumor suppressor in leukemia/lymphoma and tongue cancer. Fujioka, Y., Taira, T., Maeda, Y., Tanaka, S., Nishihara, H., Iguchi-Ariga, S.M., Nagashima, K., Ariga, H. J. Biol. Chem. (2001) [Pubmed]
  2. Inhibition of 4-nitroquinoline-1-oxide-induced rat tongue carcinogenesis by the naturally occurring plant phenolics caffeic, ellagic, chlorogenic and ferulic acids. Tanaka, T., Kojima, T., Kawamori, T., Wang, A., Suzui, M., Okamoto, K., Mori, H. Carcinogenesis (1993) [Pubmed]
  3. Second primary neoplasms among 53 159 haematolymphoproliferative malignancy patients in Sweden, 1958-1996: a search for common mechanisms. Dong, C., Hemminki, K. Br. J. Cancer (2001) [Pubmed]
  4. Oral glycopyrrolate alleviates drooling in a patient with tongue cancer. Olsen, A.K., Sjøgren, P. Journal of pain and symptom management. (1999) [Pubmed]
  5. Circulating prolactin and tumoral prolactin receptors in men with tongue cancer: a preliminary study. Patel, D.D., Bhatavdekar, J.M., Vora, H.H., Balar, D.B. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. (1994) [Pubmed]
  6. Increased incidence of tongue cancer after primary radiotherapy for nasopharyngeal carcinoma--the possibility of radiation carcinogenesis. Teo, P.M., Chan, A.T., Leung, S.F., Chau, R.M., Yu, P.K., King, W.W., Johnson, P.J. Eur. J. Cancer (1999) [Pubmed]
  7. Loss of Fhit expression is a predictor of poor outcome in tongue cancer. Lee, J.I., Soria, J.C., Hassan, K., Liu, D., Tang, X., El-Naggar, A., Hong, W.K., Mao, L. Cancer Res. (2001) [Pubmed]
  8. Chemoprevention of 4-nitroquinoline 1-oxide-induced oral carcinogenesis in rats by flavonoids diosmin and hesperidin, each alone and in combination. Tanaka, T., Makita, H., Ohnishi, M., Mori, H., Satoh, K., Hara, A., Sumida, T., Fukutani, K., Tanaka, T., Ogawa, H. Cancer Res. (1997) [Pubmed]
  9. Chemoprevention of 4-nitroquinoline 1-oxide-induced rat oral carcinogenesis by the dietary flavonoids chalcone, 2-hydroxychalcone, and quercetin. Makita, H., Tanaka, T., Fujitsuka, H., Tatematsu, N., Satoh, K., Hara, A., Mori, H. Cancer Res. (1996) [Pubmed]
  10. Chemoprevention of oral carcinogenesis by DL-alpha-difluoromethylornithine, an ornithine decarboxylase inhibitor: dose-dependent reduction in 4-nitroquinoline 1-oxide-induced tongue neoplasms in rats. Tanaka, T., Kojima, T., Hara, A., Sawada, H., Mori, H. Cancer Res. (1993) [Pubmed]
  11. Effects of bleomycin on human tongue carcinoma cells as revealed by electron microscopy. Yasuzumi, G., Hyo, Y., Hoshiya, T., Yasuzumi, F. Cancer Res. (1976) [Pubmed]
  12. An animal model for the rapid induction of tongue neoplasms in human c-Ha-ras proto-oncogene transgenic rats by 4-nitroquinoline 1-oxide: its potential use for preclinical chemoprevention studies. Suzuki, R., Kohno, H., Suzui, M., Yoshimi, N., Tsuda, H., Wakabayashi, K., Tanaka, T. Carcinogenesis (2006) [Pubmed]
  13. Silibinin inhibits invasion of oral cancer cells by suppressing the MAPK pathway. Chen, P.N., Hsieh, Y.S., Chiang, C.L., Chiou, H.L., Yang, S.F., Chu, S.C. J. Dent. Res. (2006) [Pubmed]
  14. Split course interstitial brachytherapy with a source shift: the results of a new iridium implant technique versus single course implants for salvage irradiation of base of tongue cancers in 55 patients. Housset, M., Baillet, F., Delanian, S., Brunel, P., Maulard, C., Michel-Langlet, P., Huart, J., Maylin, C., Boisserie, G. Int. J. Radiat. Oncol. Biol. Phys. (1991) [Pubmed]
  15. Acute reversible encephalopathy after repeated low-dose cisplatin infusions and concomitant radiotherapy for cancer of the tongue. Vihinen, P.P., Kätkä, K.M., Johansson, R.K., Vihinen, T.A., Salminen, E.K. Acta oncologica (Stockholm, Sweden) (2003) [Pubmed]
  16. Five quantitative trait loci affecting 4-nitroquinoline 1-oxide-induced tongue cancer in the rat. Tanuma, J.I., Fujii, K., Hirano, M., Matsuuchi, H., Shisa, H., Hiai, H., Kitano, M. Jpn. J. Cancer Res. (2001) [Pubmed]
  17. CDDP induces p53-dependent apoptosis in tongue cancer cells. Kanata, H., Yane, K., Ota, I., Miyahara, H., Matsunaga, T., Takahashi, A., Ohnishi, K., Ohnishi, T., Hosoi, H. Int. J. Oncol. (2000) [Pubmed]
  18. p53, p21, Rb, and MDM2 proteins in tongue carcinoma from patients < 35 versus > 75 years. Regezi, J.A., Dekker, N.P., McMillan, A., Ramirez-Amador, V., Meneses-Garcia, A., Ruiz-Godoy Rivera, L.M., Chrysomali, E., Ng, I.O. Oral Oncol. (1999) [Pubmed]
  19. Differential expression of cytokeratin after orthotopic implantation of newly established human tongue cancer cell lines of defined metastatic ability. Morifuji, M., Taniguchi, S., Sakai, H., Nakabeppu, Y., Ohishi, M. Am. J. Pathol. (2000) [Pubmed]
  20. Cyclin D1 and p16INK4A expression predict reduced survival in carcinoma of the anterior tongue. Bova, R.J., Quinn, D.I., Nankervis, J.S., Cole, I.E., Sheridan, B.F., Jensen, M.J., Morgan, G.J., Hughes, C.J., Sutherland, R.L. Clin. Cancer Res. (1999) [Pubmed]
  21. The antiproliferative effect of lidocaine on human tongue cancer cells with inhibition of the activity of epidermal growth factor receptor. Sakaguchi, M., Kuroda, Y., Hirose, M. Anesth. Analg. (2006) [Pubmed]
  22. New superselective intra-arterial infusion via superficial temporal artery for cancer of the tongue and tumour tissue platinum concentration after carboplatin (CBDCA) infusion. Tohnai, I., Fuwa, N., Hayashi, Y., Kaneko, R., Tomaru, Y., Hibino, Y., Ueda, M. Oral Oncol. (1998) [Pubmed]
  23. Prolactin as a local growth promoter in patients with locally advanced tongue cancer: GCRI experience. Bhatavdekar, J.M., Patel, D.D., Vora, H.H., Shah, N.G., Chikhlikar, P.R., Ghosh, N. Head & neck. (2000) [Pubmed]
  24. Correlations of oral tongue cancer invasion with matrix metalloproteinases (MMPs) and vascular endothelial growth factor (VEGF) expression. Kim, S.H., Cho, N.H., Kim, K., Lee, J.S., Koo, B.S., Kim, J.H., Chang, J.H., Choi, E.C. Journal of surgical oncology. (2006) [Pubmed]
  25. Analysis of treatment results for oral tongue cancer. Sessions, D.G., Spector, G.J., Lenox, J., Haughey, B., Chao, C., Marks, J. Laryngoscope (2002) [Pubmed]
  26. Induction chemotherapy with docetaxel, cisplatin and 5-fluorouracil for tongue cancer. Shibuya, Y., Tanimoto, H., Umeda, M., Yokoo, S., Komori, T. The Kobe journal of medical sciences. (2004) [Pubmed]
  27. In vivo antitumor effects of electrochemotherapy in a tongue cancer model. Omura, S., Tsuyuki, Y., Ohta, S., Bukawa, H., Fujita, K. J. Oral Maxillofac. Surg. (1999) [Pubmed]
WikiGenes - Universities